JCO Highlighted Genitourinary Cancers Articleshttp://jco.ascopubs.org/American Society of Clinical Oncology (ASCO)http://www.asco.org/images/ascorss.gifJCO Highlighted Genitourinary Cancers Articleshttp://jco.ascopubs.org/<![CDATA[Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial]]> <![CDATA[Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract]]> <![CDATA[Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort]]> <![CDATA[Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers]]> <![CDATA[Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy]]> <![CDATA[Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06]]> <![CDATA[Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer]]> <![CDATA[Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma]]> <![CDATA[Prostate Cancer?Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era]]> <![CDATA[Quality of Surveillance for Stage I Testis Cancer in the Community]]>